Answers are grounded in this paper and cite their sources.
Perspective reveals determinants of therapy availability in cystic fibrosis trials, highlighting implications for treatment discontinuation research.
Alex H Gifford; “Stop ‘em if you’ve got ‘em!” – Determinants and Consequences of CF Treatment Availability in Discontinuation Research, Annals of the Ameri
No takes yet. Share an insight, caveat, or question.
Alex H. Gifford (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: